Profusa, Inc.
PFSA Nasdaq· Surgical & Medical Instruments & Apparatus
Last close · Oct 23, 2026
$0.84
KIRA · Stoqly’s AI analyst, in plain words
- Profusa, Inc. lost $35.8M in fiscal 2025.
- Free cash flow was −$16.3M in fiscal 2025, — of revenue.
Market cap
$0.0M
P/E
0.0x
Revenue
—
Net income
−$35.8M
Free cash flow
−$16.3M
Operating margin
—
Profusa, Inc. in 30 seconds · fiscal 2025
Does it make a profit?
−$35.8M
No. It lost money last year.
How is the share priced?
0.0x
One share costs 0.0 times its yearly profit per share.
What Profusa, Inc. does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Apr 15, 2026
- Legal name
- Profusa, Inc.
- CIK
- 0001859807
Profusa, Inc. · PFSA
Results and finances
The last 4 fiscal years. Amounts in USD.
| Fiscal year | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Sales and profit | ||||
| Revenue | — | — | $0.1M | — |
| Operating margin | — | — | −4,500.0% | — |
| Net income | $7.2M | $1.2M | −$9.2M | −$35.8M |
| Net margin | — | — | −9,230.0% | — |
| Diluted EPS | $0.30 | $0.12 | −$357.14 | −$107.01 |
| Cash | ||||
| Cash from operations | −$0.6M | −$2.1M | −$2.1M | −$16.2M |
| Capital expenditure | — | — | — | $0.0M |
| Free cash flow | — | — | — | −$16.3M |
| Share buybacks | — | $185M | $3.2M | — |
| Share count change | — | 0.0% | −99.5% | 1,197.7% |
| Debt and strength | ||||
| Cash and short-term investments | $0.2M | $0.0M | $0.2M | $1.8M |
| Debt incl. finance leases | — | $0.2M | — | — |
| Shareholders' equity | −$0.6M | −$110M | −$119M | −$26.7M |
| Current ratio | 0.5x | 0.3x | 0.0x | 0.2x |
| Interest coverage | — | — | −1.0x | −11.0x |
| Returns and quality | ||||
| Altman Z'' | −0.4 | −26.7 | −266.0 | −221.2 |
Insiders bought, 12 months
$0.0M
1 insider
Insiders sold, 12 months
$0.2M
1 insider
Of sales under plans
0%
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Profusa, Inc. · PFSA
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $0.84 a share, the company is worth $0.0M: 0.0 times its earnings of the last four quarters.
Source: SEC EDGAR XBRL filings (CIK 0001859807). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.